BioMed Realty Trust Inc Cashflow Statement

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2014 12 months to Dec 31, 2014	FY2013 12 months to Dec 31, 2013	FY2012 12 months to Dec 31, 2012	FY2011 12 months to Dec 31, 2011
Interest Paid, Capitalized
Cash and Cash Equivalents, Period Increase (Decrease)
Net income / (loss)
BIOMED REALTY, L.P.
Parent Company
Total net income / (loss)
Adjustments to reconcile net income to net cash provided by operating activities
Loss/(gain) on derivative instruments
Depreciation and amortization
Allowance for doubtful accounts
BIOMED REALTY, L.P.
Parent Company
Total allowance for doubtful accounts
Gain (Loss) on Sale of Properties
Non-cash revenue adjustments
Other non-cash adjustments
Compensation expense related to restricted common stock and LTIP units / share-based payments
BIOMED REALTY, L.P.
Parent Company
Total compensation expense related to restricted common stock and LTIP units / share-based payments

Loss from unconsolidated partnerships
BIOMED REALTY, L.P.
Parent Company
Total loss from unconsolidated partnerships
Distributions representing a return on capital from unconsolidated partnerships

Change in operating assets and liabilities
Accounts receivable
Accrued straight-line rents
Deferred leasing costs
Other assets
Accounts payable, accrued expenses and other liabilities
Net cash provided by operating activities
Investing activities
Purchases of investments in real estate and related intangible assets
Capital expenditures
Proceeds from Sale of Property Held-for-sale
Contributions from historic tax credit transactions, net of deferred costs
Contributions from new market tax credit transactions, net of deferred costs
Draws on construction loan receivable
Proceeds from Collection of Loans Receivable
Contributions to unconsolidated partnerships, net
Purchases of debt and equity securities
Proceeds from the sale of debt and equity securities
Proceeds from Collection of Lease Receivables
Payments for (Proceeds from) Deposits on Real Estate Acquisitions
Net cash used in investing activities

Financing activities
Proceeds from issuance of OP units
Proceeds from common stock offering
Payment of offering costs
Redemption of Series A preferred stock
Payments of deferred loan costs
Unsecured line of credit proceeds
Unsecured line of credit payments
Proceeds from Issuance of Secured Debt
Mortgage notes proceeds
Principal payments on mortgage notes payable
Proceeds from unsecured senior term loans
Unsecured senior term loan payments
Repayments of Convertible Debt
Proceeds from unsecured senior notes
Repayments of Construction Loans Payable
Settlement Of Derivative Instruments
Deferred settlement payments on interest rate swaps, net
Release of restriction of cash for repayment of debt
Distributions to operating partnership unit and LTIP unit holders
Dividends paid to common stockholders / unitholders
BIOMED REALTY, L.P.
Parent Company
Dividends paid to preferred stockholders / unitholders
Net cash provided by financing activities
Effect of exchange rate changes on cash and cash equivalents
Net increase / (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Cash paid during the period for interest (net of amounts capitalized of $21,877, $14,205 and $8,644 for the years ended December 31, 2014, 2013 and 2012, respectively)
Accrual for preferred stock dividends / unit distributions declared
Accrual for common stock dividends / unit distributions declared
BIOMED REALTY, L.P.
Parent Company
Accrual for distributions declared for operating partnership unit and LTIP unit holders
Accrued additions to real estate and related intangible assets
Mortgage notes assumed (includes premiums of $3,966, $8,671 and $1,802 for the years ended December 31, 2014, 2013 and 2012, respectively)
Equity issued in connection with Wexford merger and 320 Charles Street acquisition
Stock Issued During Period, Value, Conversion of Convertible Securities
BIOMED REALTY, L.P.
Parent Company
equity issued in connection with 100 college street and 300 george street acquisition
Deposits applied for acquisitions
Debt Instrument, Unamortized Premium

Comments